OKYO Pharma Ltd (NASDAQ:OKYO) earlier this week confirmed it is set to launch a Phase 2b/3 clinical trial for neuropathic corneal pain, following ...

Virtuix Holdings Inc (NASDAQ:VTIX) earlier this week marked a significant milestone with its listing on the Nasdaq under the ticker symbol VTIX, as ...

CEO Alberto Rosende talked with Proactive about the company's mission to reshape the U.S. critical minerals supply chain. In ...

CEO Sam Tabar talked with Proactive about the company's major strategic shift in 2025 and its positioning at the ...

CEO Brian Fowler joined Proactive to discuss discussed the recent approval of up to $4 million in funding from ...

Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) this week reaffirmed its focus on capital efficiency and pipeline advancement following a ...

OKYO Pharma Ltd (NASDAQ:OKYO), a clinical-stage biopharmaceutical company focused on therapies for neuropathic corneal pain (NCP) and inflammatory ...

Metals rally collapses Stocks slipped on Friday as investors digested President Trump’s announcement that he will nominate Kevin Warsh to lead ...

FTSE 100 gains 6 points to 10,178 Gold, silver and copper retreat from recent highs Fed chair nomination expected today 9.10am: Greenback "back in ...

FTSE 100 gains 53 points to 10,225 Gold, silver and copper retreat from recent highs Fed chair nomination expected today US index futures sink ...

Phunware Inc (NASDAQ:PHUN, FRA:2RJA) earlier this week unveiled a redesigned corporate website as part of its sharpened focus on the hospitality sector.

AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) is paying $1.2 billion up-front to seal a tie-up with a Chinese pharma giant aimed at expanding its weight-loss ...